Exact Mass: 745.5678644

Exact Mass Matches: 745.5678644

Found 317 metabolites which its exact mass value is equals to given mass value 745.5678644, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PC(15:0/18:1(9Z))

trimethyl(2-{[(2R)-2-[(9Z)-octadec-9-enoyloxy]-3-(pentadecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C41H80NO8P (745.562125)


PC(15:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/18:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of oleic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(15:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/18:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of oleic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(18:0/18:1(9Z))

(2-aminoethoxy)[(2R)-2-[(9Z)-octadec-9-enoyloxy]-3-(octadecanoyloxy)propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE(18:0/18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/18:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of oleic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(18:0/18:1(9Z)) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(18:0/18:1(9Z)), in particular, consists of one octadecanoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(18:1(9Z)/18:0)

(2-aminoethoxy)[(2R)-3-[(9Z)-octadec-9-enoyloxy]-2-(octadecanoyloxy)propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE(18:1(9Z)/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:1(9Z)/18:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of stearic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(18:1(9Z)/18:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(18:1(9Z)/18:0), in particular, consists of one 9Z-octadecenoyl chain to the C-1 atom, and one octadecanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PC(15:0/18:1(11Z))

trimethyl(2-{[(2R)-2-[(11Z)-octadec-11-enoyloxy]-3-(pentadecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C41H80NO8P (745.562125)


PC(15:0/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/18:1(11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(15:0/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/18:1(11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(18:1(11Z)/15:0)

trimethyl(2-{[(2R)-3-[(11Z)-octadec-11-enoyloxy]-2-(pentadecanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C41H80NO8P (745.562125)


PC(18:1(11Z)/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/15:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:1(11Z)/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/15:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(18:1(9Z)/15:0)

1-(9Z-Octadecenoyl)-2-pentadecanoyl-sn-glycero-3-phosphocholine

C41H80NO8P (745.562125)


PC(18:1(9Z)/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/15:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PE(14:0/22:1(13Z))

(2-aminoethoxy)[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-(tetradecanoyloxy)propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE(14:0/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:0/22:1(13Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of erucic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(14:0/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:0/22:1(13Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of erucic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(14:1(9Z)/22:0)

(2-aminoethoxy)[(2R)-2-(docosanoyloxy)-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE(14:1(9Z)/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:1(9Z)/22:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of behenic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(16:0/20:1(11Z))

(2-aminoethoxy)[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-icos-11-enoyloxy]propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE(16:0/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:0/20:1(11Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(16:1(9Z)/20:0)

(2-aminoethoxy)[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-(icosanoyloxy)propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE(16:1(9Z)/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:1(9Z)/20:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(16:1(9Z)/20:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(16:1(9Z)/20:0), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one eicosanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(18:0/18:1(11Z))

(2-aminoethoxy)[(2R)-2-[(11Z)-octadec-11-enoyloxy]-3-(octadecanoyloxy)propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE(18:0/18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/18:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(18:0/18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/18:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(18:1(11Z)/18:0)

(2-aminoethoxy)[(2R)-3-[(11Z)-octadec-11-enoyloxy]-2-(octadecanoyloxy)propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE(18:1(11Z)/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:1(11Z)/18:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of stearic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(20:0/16:1(9Z))

(2-aminoethoxy)[(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-(icosanoyloxy)propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE(20:0/16:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/16:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(20:0/16:1(9Z)) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(20:0/16:1(9Z)), in particular, consists of one eicosanoyl chain to the C-1 atom, and one 9Z-hexadecenoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(20:1(11Z)/16:0)

(2-aminoethoxy)[(2R)-2-(hexadecanoyloxy)-3-[(11Z)-icos-11-enoyloxy]propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE(20:1(11Z)/16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/16:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(22:0/14:1(9Z))

(2-aminoethoxy)[(2R)-3-(docosanoyloxy)-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE(22:0/14:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/14:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(22:1(13Z)/14:0)

(2-aminoethoxy)[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-(tetradecanoyloxy)propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE(22:1(13Z)/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:1(13Z)/14:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of myristic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE-NMe2(16:0/18:1(9Z))

[2-(dimethylamino)ethoxy][(2R)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE-NMe2(16:0/18:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(16:0/18:1(9Z)), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. PE-NMe2(16:0/18:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. (Lipid Library, Lipid MAPS) [HMDB]

   

PE-NMe(15:0/20:1(11Z))

{2-[(11Z)-icos-11-enoyloxy]-3-(pentadecanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C41H80NO8P (745.562125)


PE-NMe(15:0/20:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(15:0/20:1(11Z)), in particular, consists of one pentadecanoyl chain to the C-1 atom, and one 11Z-eicosenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(20:1(11Z)/15:0)

{3-[(11Z)-icos-11-enoyloxy]-2-(pentadecanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid

C41H80NO8P (745.562125)


PE-NMe(20:1(11Z)/15:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:1(11Z)/15:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(14:0/20:1(11Z))

[2-(dimethylamino)ethoxy]({2-[(11Z)-icos-11-enoyloxy]-3-(tetradecanoyloxy)propoxy})phosphinic acid

C41H80NO8P (745.562125)


PE-NMe2(14:0/20:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(14:0/20:1(11Z)), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one 11Z-eicosenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe2(14:1(9Z)/20:0)

[2-(dimethylamino)ethoxy][2-(icosanoyloxy)-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE-NMe2(14:1(9Z)/20:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(14:1(9Z)/20:0), in particular, consists of one 9Z-tetradecenoyl chain to the C-1 atom, and one eicosanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe2(16:0/18:1(11Z))

[2-(dimethylamino)ethoxy][3-(hexadecanoyloxy)-2-[(11Z)-octadec-11-enoyloxy]propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE-NMe2(16:0/18:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(16:0/18:1(11Z)), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one 11Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe2(16:1(9Z)/18:0)

[2-(dimethylamino)ethoxy]({3-[(9Z)-hexadec-9-enoyloxy]-2-(octadecanoyloxy)propoxy})phosphinic acid

C41H80NO8P (745.562125)


PE-NMe2(16:1(9Z)/18:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(16:1(9Z)/18:0), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one octadecanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe2(18:0/16:1(9Z))

[2-(dimethylamino)ethoxy]({2-[(9Z)-hexadec-9-enoyloxy]-3-(octadecanoyloxy)propoxy})phosphinic acid

C41H80NO8P (745.562125)


PE-NMe2(18:0/16:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:0/16:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(18:1(11Z)/16:0)

[2-(dimethylamino)ethoxy][2-(hexadecanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE-NMe2(18:1(11Z)/16:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:1(11Z)/16:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(18:1(9Z)/16:0)

[2-(dimethylamino)ethoxy][2-(hexadecanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE-NMe2(18:1(9Z)/16:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:1(9Z)/16:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(20:0/14:1(9Z))

[2-(dimethylamino)ethoxy][3-(icosanoyloxy)-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C41H80NO8P (745.562125)


PE-NMe2(20:0/14:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:0/14:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(20:1(11Z)/14:0)

[2-(dimethylamino)ethoxy]({3-[(11Z)-icos-11-enoyloxy]-2-(tetradecanoyloxy)propoxy})phosphinic acid

C41H80NO8P (745.562125)


PE-NMe2(20:1(11Z)/14:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:1(11Z)/14:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PC(16:1(9Z)/17:0)

(2-{[2-(heptadecanoyloxy)-3-(hexadec-9-enoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C41H80NO8P (745.562125)


   

Stearoyl-oleoyl-phosphatidyl ethanolamine

(2-aminoethoxy)[2-(octadec-9-enoyloxy)-3-(octadecanoyloxy)propoxy]phosphinic acid

C41H80NO8P (745.562125)


   

Phosphatidylethanolamine 16:0-20:1

Phosphatidylethanolamine 16:0-20:1

C41H80NO8P (745.562125)


   

Phosphatidylethanolamine 18:0-18:1

Phosphatidylethanolamine 18:0-18:1

C41H80NO8P (745.562125)


   

PC 33:1

1-pentadecanoyl-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C41H80NO8P (745.562125)


Found in mouse spleen; TwoDicalId=414; MgfFile=160729_spleen_EPA_09_Neg; MgfId=983 Found in mouse muscle; TwoDicalId=254; MgfFile=160824_Muscle_AA_Neg_19; MgfId=868 Found in mouse small intestine; TwoDicalId=750; MgfFile=160907_Small_Intestine_normal_Neg_01_never; MgfId=1203

   
   
   

termitomycesphin E

N-(2R-hydroxy-hexadecanoyl)-1-beta-glucosyl-8-hydroxy,9-methyl-sphing-4E-enine

C41H79NO10 (745.5703674)


   

PE 36:1

7-Octadecenoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxooctadecyl)oxy]ethyl ester, [R-(Z)]- (9CI)

C41H80NO8P (745.562125)


Found in mouse brain; TwoDicalId=72; MgfFile=160720_brain_AA_18_Neg; MgfId=1626

   

(2-aminoethoxy)[2-[octadec-9-enoyloxy]-3-(octadecanoyloxy)propoxy]phosphinic acid

(2-aminoethoxy)[2-[octadec-9-enoyloxy]-3-(octadecanoyloxy)propoxy]phosphinic acid

C41H80NO8P (745.562125)


   
   

Phosphatidylethanolamine (18:0/18:1) Abbr: SOPE

Phosphatidylethanolamine (18:0/18:1) Abbr: SOPE

C41H80NO8P (745.562125)


   

PC(15:0/18:1)[U]

3,5,8-Trioxa-4-phosphahexacos-17-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxopentadecyl)oxy]methyl]-, inner salt, 4-oxide, (Z)-

C41H80NO8P (745.562125)


   

PC(16:0/17:1)

3,5,8-Trioxa-4-phosphapentacos-17-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxohexadecyl)oxy]methyl]-, inner salt, 4-oxide, [R-(Z)]-

C41H80NO8P (745.562125)


   

PC(16:0/17:1)[U]

3,5,8-Trioxa-4-phosphapentacos-17-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxohexadecyl)oxy]methyl]-, inner salt, 4-oxide, (Z)-

C41H80NO8P (745.562125)


   

Olein, 1-

Ethanol, 2-amino-, dihydrogen phosphate (ester), monoester with 1-stearo-2-olein

C41H80NO8P (745.562125)


   

PE(18:0/18:1)

7-Octadecenoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxooctadecyl)oxy]ethyl ester, [R-(Z)]- (9CI)

C41H80NO8P (745.562125)


   

PE(18:0/18:1)[U]

9-Octadecenoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxooctadecyl)oxy]ethyl ester, (E)-

C41H80NO8P (745.562125)


   

PE(18:1/18:0)[U]

1-(9E-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

PE(18:1/18:0)

9-Octadecenoic acid (Z)-, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxooctadecyl)oxy]propyl ester, (R)-

C41H80NO8P (745.562125)


   

PE(16:0/20:1)

11-Eicosenoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester, [R-(Z)]- (9CI)

C41H80NO8P (745.562125)


   

PE-NMe2(16:0/18:1)

9-Octadecenoic acid (Z)-, 4-hydroxy-8-methyl-1-[[(1-oxohexadecyl)oxy]methyl]-3,5-dioxa-8-aza-4-phosphanon-1-yl ester, P-oxid

C41H80NO8P (745.562125)


   

PE-NMe2(18:1/16:0)

9-Octadecenoic acid (Z)-, 5-hydroxy-9-methyl-5-oxido-2-[(1-oxohexadecyl)oxy]-4,6-dioxa-9-aza-5-phosphadeca-1-yl ester, (R)-

C41H80NO8P (745.562125)


   

Lecithin

1-Vaccenoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

PE(36:1)

1-Arachidonyl-2-palmitoleoyl-sn-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

PC(13:0/20:1(11Z))

1-tridecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

PC(14:0/19:1(9Z))

1-tetradecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

PC(14:1(9Z)/19:0)

1-(9Z-tetradecenoyl)-2-nonadecanoyl-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

PC(15:1(9Z)/18:0)

1-(9Z-pentadecenoyl)-2-octadecanoyl-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

PC(16:1(9Z)/17:0)

1-(9Z-hexadecenoyl)-2-heptadecanoyl-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

PC(17:0/16:1(9Z))

1-heptadecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

PC(17:1(9Z)/16:0)

1-(9Z-heptadecenoyl)-2-hexadecanoyl-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

PC(18:0/15:1(9Z))

1-octadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

PC(19:0/14:1(9Z))

1-nonadecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

PC(19:1(9Z)/14:0)

1-(9Z-nonadecenoyl)-2-tetradecanoyl-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

PC(20:1(11Z)/13:0)

1-(11Z-eicosenoyl)-2-tridecanoyl-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

PE(14:0/22:1(11Z))

1-tetradecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

PE(15:1(9Z)/21:0)

1-(9Z-pentadecenoyl)-2-heneicosanoyl-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

PE(17:0/19:1(9Z))

1-heptadecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

PE(17:1(9Z)/19:0)

1-(9Z-heptadecenoyl)-2-nonadecanoyl-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

PE(19:0/17:1(9Z))

1-nonadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

PE(19:1(9Z)/17:0)

1-(9Z-nonadecenoyl)-2-heptadecanoyl-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

PE(21:0/15:1(9Z))

1-heneicosanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

PE(22:1(11Z)/14:0)

1-(11Z-docosenoyl)-2-tetradecanoyl-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

PE-NMe2 34:1

9-Octadecenoic acid (Z)-, 4-hydroxy-8-methyl-4-oxido-1-[[(1-oxohexadecyl)oxy]methyl]-3,5-dioxa-8-aza-4-phosphanon-1-yl ester, (R)-

C41H80NO8P (745.562125)


   

2-Azaniumylethyl (2R)-2-[(9Z)-octadec-9-enoyloxy]-3-(stearoyloxy)propyl phosphate

2-Azaniumylethyl (2R)-2-[(9Z)-octadec-9-enoyloxy]-3-(stearoyloxy)propyl phosphate

C41H80NO8P (745.562125)


   

1-Stearoyl-2-oleoylphosphatidylethanolamine

1-Stearoyl-2-oleoylphosphatidylethanolamine

C41H80NO8P (745.562125)


   

[2-[(Z)-octadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-octadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-heptadec-9-enoyl]oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] octadecanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] octadecanoate

C41H80NO8P (745.562125)


   

[2-heptadecanoyloxy-3-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-heptadecanoyloxy-3-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

2-azaniumylethyl (2R)-2-(octadecanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propyl phosphate

2-azaniumylethyl (2R)-2-(octadecanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propyl phosphate

C41H80NO8P (745.562125)


   

N-stearoyl-1-oleoyl-sn-glycero-3-phosphoethanolamine

N-stearoyl-1-oleoyl-sn-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

[2-[(Z)-icos-11-enoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-icos-11-enoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

HexCer 8:0;3O/27:1;(2OH)

HexCer 8:0;3O/27:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 9:0;3O/26:1;(2OH)

HexCer 9:0;3O/26:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 11:0;3O/24:1;(2OH)

HexCer 11:0;3O/24:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 13:1;3O/22:0;(2OH)

HexCer 13:1;3O/22:0;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 13:0;3O/22:1;(2OH)

HexCer 13:0;3O/22:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 12:0;3O/23:1;(2OH)

HexCer 12:0;3O/23:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 10:0;3O/25:1;(2OH)

HexCer 10:0;3O/25:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 12:1;3O/23:0;(2OH)

HexCer 12:1;3O/23:0;(2OH)

C41H79NO10 (745.5703674)


   

(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]henicosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]henicosa-4,8,12-triene-1-sulfonic acid

C45H79NO5S (745.5678644)


   

(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxytricos-4-ene-1-sulfonic acid

(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxytricos-4-ene-1-sulfonic acid

C45H79NO5S (745.5678644)


   

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]pentacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]pentacosa-4,8,12-triene-1-sulfonic acid

C45H79NO5S (745.5678644)


   

(4E,8E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxytricosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxytricosa-4,8-diene-1-sulfonic acid

C45H79NO5S (745.5678644)


   

(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]henicosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]henicosa-4,8-diene-1-sulfonic acid

C45H79NO5S (745.5678644)


   

(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]henicos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]henicos-4-ene-1-sulfonic acid

C45H79NO5S (745.5678644)


   

(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]pentacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]pentacos-4-ene-1-sulfonic acid

C45H79NO5S (745.5678644)


   

(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxynonadec-4-ene-1-sulfonic acid

(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxynonadec-4-ene-1-sulfonic acid

C45H79NO5S (745.5678644)


   

(4E,8E,12E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxytricosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxytricosa-4,8,12-triene-1-sulfonic acid

C45H79NO5S (745.5678644)


   

2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxynonadecane-1-sulfonic acid

2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxynonadecane-1-sulfonic acid

C45H79NO5S (745.5678644)


   

3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]henicosane-1-sulfonic acid

3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]henicosane-1-sulfonic acid

C45H79NO5S (745.5678644)


   

(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxynonadeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxynonadeca-4,8-diene-1-sulfonic acid

C45H79NO5S (745.5678644)


   

(4E,8E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]pentacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]pentacosa-4,8-diene-1-sulfonic acid

C45H79NO5S (745.5678644)


   

2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxytricosane-1-sulfonic acid

2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxytricosane-1-sulfonic acid

C45H79NO5S (745.5678644)


   

(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxynonadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxynonadeca-4,8,12-triene-1-sulfonic acid

C45H79NO5S (745.5678644)


   

1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phosphocholine-d7

1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phosphocholine-d7

C41H80NO8P (745.562125)


   

2-[4-[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

2-[4-[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C48H75NO5 (745.564494)


   

Cer 14:0;2O/16:5;(3OH)(FA 18:5)

Cer 14:0;2O/16:5;(3OH)(FA 18:5)

C48H75NO5 (745.564494)


   

Cer 14:0;2O/18:5;(3OH)(FA 16:5)

Cer 14:0;2O/18:5;(3OH)(FA 16:5)

C48H75NO5 (745.564494)


   

Cer 16:0;2O/16:5;(3OH)(FA 16:5)

Cer 16:0;2O/16:5;(3OH)(FA 16:5)

C48H75NO5 (745.564494)


   

[(2R)-1,1,2,3,3-pentadeuterio-3-heptadecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-1,1,2,3,3-pentadeuterio-3-heptadecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

HexCer 18:1;3O/17:0;(2OH)

HexCer 18:1;3O/17:0;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 23:1;3O/12:0;(2OH)

HexCer 23:1;3O/12:0;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 19:1;3O/16:0;(2OH)

HexCer 19:1;3O/16:0;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 16:1;3O/19:0;(2OH)

HexCer 16:1;3O/19:0;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 22:0;3O/13:1;(2OH)

HexCer 22:0;3O/13:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 17:0;3O/18:1;(2OH)

HexCer 17:0;3O/18:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 14:1;3O/21:0;(2OH)

HexCer 14:1;3O/21:0;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 21:0;3O/14:1;(2OH)

HexCer 21:0;3O/14:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 19:0;3O/16:1;(2OH)

HexCer 19:0;3O/16:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 16:0;3O/19:1;(2OH)

HexCer 16:0;3O/19:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 22:1;3O/13:0;(2OH)

HexCer 22:1;3O/13:0;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 20:1;3O/15:0;(2OH)

HexCer 20:1;3O/15:0;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 20:0;3O/15:1;(2OH)

HexCer 20:0;3O/15:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 14:0;3O/21:1;(2OH)

HexCer 14:0;3O/21:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 15:1;3O/20:0;(2OH)

HexCer 15:1;3O/20:0;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 15:0;3O/20:1;(2OH)

HexCer 15:0;3O/20:1;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 21:1;3O/14:0;(2OH)

HexCer 21:1;3O/14:0;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 17:1;3O/18:0;(2OH)

HexCer 17:1;3O/18:0;(2OH)

C41H79NO10 (745.5703674)


   

HexCer 23:0;3O/12:1;(2OH)

HexCer 23:0;3O/12:1;(2OH)

C41H79NO10 (745.5703674)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (Z)-octacos-17-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (Z)-octacos-17-enoate

C41H80NO8P (745.562125)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (Z)-icos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (Z)-icos-11-enoate

C41H80NO8P (745.562125)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-henicos-11-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C41H80NO8P (745.562125)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] henicosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] henicosanoate

C41H80NO8P (745.562125)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (Z)-nonadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (Z)-nonadec-9-enoate

C41H80NO8P (745.562125)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] icosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] icosanoate

C41H80NO8P (745.562125)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] nonadecanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] nonadecanoate

C41H80NO8P (745.562125)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tricosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tricosanoate

C41H80NO8P (745.562125)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] (Z)-hexacos-15-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] (Z)-hexacos-15-enoate

C41H80NO8P (745.562125)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] docosanoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] docosanoate

C41H80NO8P (745.562125)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (Z)-docos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (Z)-docos-13-enoate

C41H80NO8P (745.562125)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

C41H80NO8P (745.562125)


   

[3-heptadecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-heptadecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[3-nonadecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-nonadecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (9Z,11E)-13-hydroxyoctadeca-9,11-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (9Z,11E)-13-hydroxyoctadeca-9,11-dienoate

C41H80NO8P (745.562125)


   

[3-octadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-octadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-nonadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[2-[(Z)-docos-13-enoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-docos-13-enoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (E)-10-hydroxyoctadec-12-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (E)-10-hydroxyoctadec-12-enoate

C41H80NO8P (745.562125)


   

[3-heptanoyloxy-2-[(Z)-hexacos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-heptanoyloxy-2-[(Z)-hexacos-15-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate

C41H80NO8P (745.562125)


   

[3-dodecanoyloxy-2-[(Z)-henicos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-dodecanoyloxy-2-[(Z)-henicos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[3-icosanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-icosanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] 10-(3-hexyloxiran-2-yl)decanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] 10-(3-hexyloxiran-2-yl)decanoate

C41H80NO8P (745.562125)


   

[3-nonanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-nonanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

2-[[1-O-Stearoyl-2-O-(9-octadecenoyl)-L-glycero-3-phospho]oxy]ethanamine

2-[[1-O-Stearoyl-2-O-(9-octadecenoyl)-L-glycero-3-phospho]oxy]ethanamine

C41H80NO8P (745.562125)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] (E)-docos-13-enoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] (E)-docos-13-enoate

C41H80NO8P (745.562125)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] (E)-icos-11-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] (E)-icos-11-enoate

C41H80NO8P (745.562125)


   

[(2R)-2-[(E)-heptadec-9-enoyl]oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-heptadec-9-enoyl]oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] henicosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] henicosanoate

C41H80NO8P (745.562125)


   

[(2R)-2-octadecanoyloxy-3-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-octadecanoyloxy-3-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadec-17-enoyloxypropan-2-yl] octadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadec-17-enoyloxypropan-2-yl] octadecanoate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] docosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] docosanoate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (E)-icos-11-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (E)-icos-11-enoate

C41H80NO8P (745.562125)


   

[(2R)-3-[(E)-octadec-9-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-9-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] nonadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] nonadecanoate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] (E)-hexacos-5-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] (E)-hexacos-5-enoate

C41H80NO8P (745.562125)


   

[(2R)-3-heptadecanoyloxy-2-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-heptadecanoyloxy-2-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] icosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] icosanoate

C41H80NO8P (745.562125)


   

[(2R)-3-octadec-17-enoyloxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-octadec-17-enoyloxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-4-enoyl]oxypropan-2-yl] octadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-4-enoyl]oxypropan-2-yl] octadecanoate

C41H80NO8P (745.562125)


   

[(2S)-3-[(E)-icos-11-enoyl]oxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-[(E)-icos-11-enoyl]oxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] icosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] icosanoate

C41H80NO8P (745.562125)


   

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-icos-13-enoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-7-enoyl]oxypropan-2-yl] octadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-7-enoyl]oxypropan-2-yl] octadecanoate

C41H80NO8P (745.562125)


   

[(2R)-3-nonadecanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-nonadecanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-2-[(E)-octadec-11-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-octadec-11-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-3-[(E)-octadec-6-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-6-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] (E)-tetracos-15-enoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] (E)-tetracos-15-enoate

C41H80NO8P (745.562125)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-decanoyloxypropyl] (E)-hexacos-5-enoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-decanoyloxypropyl] (E)-hexacos-5-enoate

C41H80NO8P (745.562125)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] (E)-icos-13-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] (E)-icos-13-enoate

C41H80NO8P (745.562125)


   

[(2R)-2-octadec-17-enoyloxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-octadec-17-enoyloxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-octadec-17-enoyloxypropyl] octadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-octadec-17-enoyloxypropyl] octadecanoate

C41H80NO8P (745.562125)


   

[(2S)-3-[(E)-icos-13-enoyl]oxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-[(E)-icos-13-enoyl]oxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] henicosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] henicosanoate

C41H80NO8P (745.562125)


   

[(2R)-3-[(E)-octadec-7-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-7-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (E)-icos-13-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (E)-icos-13-enoate

C41H80NO8P (745.562125)


   

[(2R)-2-[(E)-octadec-6-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-octadec-6-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] icosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] icosanoate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-9-enoyl]oxypropan-2-yl] octadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-9-enoyl]oxypropan-2-yl] octadecanoate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-11-enoyl]oxypropan-2-yl] octadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-11-enoyl]oxypropan-2-yl] octadecanoate

C41H80NO8P (745.562125)


   

[(2R)-3-[(E)-octadec-11-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-11-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-3-octadecanoyloxy-2-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-octadecanoyloxy-2-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-3-[(E)-octadec-4-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-4-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] nonadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] nonadecanoate

C41H80NO8P (745.562125)


   

[(2R)-2-heptadecanoyloxy-3-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-heptadecanoyloxy-3-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-13-enoyl]oxypropan-2-yl] octadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-13-enoyl]oxypropan-2-yl] octadecanoate

C41H80NO8P (745.562125)


   

[(2R)-3-[(E)-octadec-13-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-octadec-13-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] docosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] docosanoate

C41H80NO8P (745.562125)


   

[(2S)-3-[(E)-docos-13-enoyl]oxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-[(E)-docos-13-enoyl]oxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-2-heptadecanoyloxy-3-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-heptadecanoyloxy-3-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] octadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-6-enoyl]oxypropyl] octadecanoate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (E)-docos-13-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (E)-docos-13-enoate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-6-enoyl]oxypropan-2-yl] octadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-6-enoyl]oxypropan-2-yl] octadecanoate

C41H80NO8P (745.562125)


   

[(2R)-3-heptadecanoyloxy-2-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-heptadecanoyloxy-2-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-2-[(E)-octadec-7-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-octadec-7-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-3-[(E)-heptadec-9-enoyl]oxy-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-[(E)-heptadec-9-enoyl]oxy-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] octadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-7-enoyl]oxypropyl] octadecanoate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-7-enoyl]oxypropan-2-yl] icosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-7-enoyl]oxypropan-2-yl] icosanoate

C41H80NO8P (745.562125)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (E)-tetracos-15-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (E)-tetracos-15-enoate

C41H80NO8P (745.562125)


   

[(2R)-2-nonadecanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-nonadecanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-2-[(E)-octadec-4-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-octadec-4-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-2-[(E)-octadec-13-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-octadec-13-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] octadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-4-enoyl]oxypropyl] octadecanoate

C41H80NO8P (745.562125)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] octadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-11-enoyl]oxypropyl] octadecanoate

C41H80NO8P (745.562125)


   

[(2R)-2-[(E)-octadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(E)-octadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H80NO8P (745.562125)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] octadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-octadec-13-enoyl]oxypropyl] octadecanoate

C41H80NO8P (745.562125)


   

1-Oleoyl-2-stearoyl-sn-glycero-3-phosphoethanolamine

1-Oleoyl-2-stearoyl-sn-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituents at positions 1 and 2 are specified as oleoyl and stearoyl respectively.

   

PE-NMe2(16:0/18:1(9Z))

PE-NMe2(16:0/18:1(9Z))

C41H80NO8P (745.562125)


   

1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phosphocholine

1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phosphocholine

C41H80NO8P (745.562125)


A phosphatidylcholine 33:1 in which the 1- and 2-acyl groups are specified as pentadecanoyl and oleoyl respectively.

   

1-(11Z-eicosenoyl)-2-hexadecanoyl-glycero-3-phosphoethanolamine

1-(11Z-eicosenoyl)-2-hexadecanoyl-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

1-(9Z-octadecenoyl)-2-pentadecanoyl-glycero-3-phosphocholine

1-(9Z-octadecenoyl)-2-pentadecanoyl-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

1-(9Z-tetradecenoyl)-2-docosanoyl-glycero-3-phosphoethanolamine

1-(9Z-tetradecenoyl)-2-docosanoyl-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

1-(9Z-hexadecenoyl)-2-eicosanoyl-glycero-3-phosphoethanolamine

1-(9Z-hexadecenoyl)-2-eicosanoyl-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

1-eicosanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

1-eicosanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

1-docosanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

1-docosanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

1-hexadecanoyl-2-(11Z-eicosenoyl)-sn-glycero-3-phosphoethanolamine

1-hexadecanoyl-2-(11Z-eicosenoyl)-sn-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

1-pentadecanoyl-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

1-pentadecanoyl-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

1-Vaccenoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

1-Vaccenoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C41H80NO8P (745.562125)


   

Phophatidylethanolamine(14:0/22:1)

Phophatidylethanolamine(14:0/22:1)

C41H80NO8P (745.562125)


   

1-Stearoyl-2-vaccenoyl-sn-glycero-3-phosphoethanolamine

1-Stearoyl-2-vaccenoyl-sn-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

1-Vaccenoyl-2-stearoyl-sn-glycero-3-phosphoethanolamine

1-Vaccenoyl-2-stearoyl-sn-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

Phophatidylethanolamine(22:1/14:0)

Phophatidylethanolamine(22:1/14:0)

C41H80NO8P (745.562125)


   

1-palmitoyl-2-(9Z-heptadecenoyl)-sn-glycero-3-phosphocholine

1-palmitoyl-2-(9Z-heptadecenoyl)-sn-glycero-3-phosphocholine

C41H80NO8P (745.562125)


A phosphatidylcholine 33:1 in which the acyl groups specified at positions 1 and 2 are palmitoyl and (9Z)-heptadecenoyl respectively.

   

1-(9Z-pentadecenoyl)-2-heneicosanoyl-glycero-3-phosphoethanolamine

1-(9Z-pentadecenoyl)-2-heneicosanoyl-glycero-3-phosphoethanolamine

C41H80NO8P (745.562125)


   

phosphatidylethanolamine (16:0/20:1)

phosphatidylethanolamine (16:0/20:1)

C41H80NO8P (745.562125)


1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl group at C-1 contains 16 carbons and no double bonds while that at C-2 contains 20 carbons and 1 double bond.

   

phosphatidylethanolamine (18:0/18:1)

phosphatidylethanolamine (18:0/18:1)

C41H80NO8P (745.562125)


A phosphatidylethanolamine 36:1 in which the acyl group at C-1 contains 18 carbons and no double bonds while that at C-2 contains 18 carbons and 1 double bond.

   

phosphatidylcholine 33:1

phosphatidylcholine 33:1

C41H80NO8P (745.562125)


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups specified at C-1 and C-2 contain 33 carbons in total with 1 double bond.

   

phosphatidylethanolamine 36:1

phosphatidylethanolamine 36:1

C41H80NO8P (745.562125)


A phosphatidylethanolamine in which the two acyl groups contain a total of 36 carbons and 1 double bond.

   

phosphatidylethanolamine 36:1 zwitterion

phosphatidylethanolamine 36:1 zwitterion

C41H80NO8P (745.562125)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 36 carbons in total with 1 double bond.

   

phosphatidylcholine (15:0/18:1)

phosphatidylcholine (15:0/18:1)

C41H80NO8P (745.562125)


A phosphatidylcholine 33:1 in which the fatty acyl groups at positions 1 and 2 are specified as C15:0 and C18:1 respectively.

   

phosphatidylcholine (16:0/17:1)

phosphatidylcholine (16:0/17:1)

C41H80NO8P (745.562125)


A phosphatidylcholine 33:1 in which the fatty acyl groups at positions 1 and 2 are specified as C16:0 and C17:1 respectively.

   

1-stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine zwitterion

1-stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine zwitterion

C41H80NO8P (745.562125)


A phosphatidylethanolamine 36:1 zwitterion obtained by transfer of a proton from the amino to the phosphate group of 1-stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine.

   

1-oleoyl-2-stearoyl-sn-glycero-3-phosphoethanolamine zwitterion

1-oleoyl-2-stearoyl-sn-glycero-3-phosphoethanolamine zwitterion

C41H80NO8P (745.562125)


A phosphatidylethanolamine 36:1 zwitterion obtained by transfer of a proton from the amino to the phosphate group of 1-oleoyl-2-stearoyl-sn-glycero-3-phosphoethanolamine; major species at pH 7.3.

   

MePC(32:1)

MePC(16:0_16:1)

C41H80NO8P (745.562125)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

dMePE(34:1)

dMePE(16:0_18:1)

C41H80NO8P (745.562125)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

CerP(41:2)

CerP(d23:2_18:0(2+O))

C41H80NO8P (745.562125)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

BisMePE(34:1)

BisMePE(16:0_18:1)

C41H80NO8P (745.562125)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

n-[(2s,3s,4r,8z)-3,4-dihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}nonadec-8-en-2-yl]-2-hydroxyhexadecanimidic acid

n-[(2s,3s,4r,8z)-3,4-dihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}nonadec-8-en-2-yl]-2-hydroxyhexadecanimidic acid

C41H79NO10 (745.5703674)